/ONPH
ONPH Stock - Oncology Pharma Inc.
Healthcare|BiotechnologyOTC
$0.01-50.00%
$0.01 (-50.00%) • Dec 19
80
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
High Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.100
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.01
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ONPH
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.01
TARGET (TP)$0.01
STOP LOSS$0.00
RISK/REWARD1:1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-8.42
52W High$0.01
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2021 | FY2020 | FY2019 | FY2018 | FY2004 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | $1.18M |
| Gross Profit | N/A | $-779 | $-1,109 | $-1,109 | $527,000 |
| Gross Margin | N/A | N/A | N/A | N/A | 44.6% |
| Operating Income | $-62,050 | $-14,411,390 | $-403,880 | $-818,860 | $-1,701,000 |
| Net Income | $-104,626,728 | $-97,473,125 | $-207,556 | $-850,396 | $-1,565,000 |
| Net Margin | N/A | N/A | N/A | N/A | -132.5% |
| EPS | $-3.42 | $-6.76 | $-0.12 | $-0.72 | $-782500.00 |
Company Overview
Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ONPHBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.01
Q4 2022
EPS Surprise History
Q4 03
No data
Q1 04
No data
Q1 04
No data
Q2 04
No data
Q3 04
No data
Q4 04
No data
Q3 22
No data
Q4 22
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2022 | Dec 31, 2022 | — | $-0.01 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.15 | — | — |
Q4 2004 | Dec 31, 2004 | — | $-40500.00 | — | — |
Q3 2004 | Sep 30, 2004 | — | $-7500.00 | — | — |
Q2 2004 | Jun 30, 2004 | — | $-89000.00 | — | — |
Q1 2004 | Mar 31, 2004 | — | $-195625.00 | — | — |
Q1 2004 | Feb 15, 2004 | — | $-20000000.00 | — | — |
Q4 2003 | Dec 31, 2003 | — | $-264000.00 | — | — |
Q4 2003 | Nov 3, 2003 | — | $-20000000.00 | — | — |
Q3 2003 | Sep 30, 2003 | — | $-216500.00 | — | — |
Q3 2003 | Aug 4, 2003 | — | $-20000000.00 | — | — |
Q2 2003 | Jun 30, 2003 | — | $-371000.00 | — | — |
Q1 2003 | Jan 31, 2003 | — | $-30000000.00 | — | — |
Q4 2002 | Dec 31, 2002 | — | $-547000.00 | — | — |
Q1 2002 | Mar 31, 2002 | — | $-487750.00 | — | — |
Q3 2001 | Sep 30, 2001 | — | $-741000.00 | — | — |
Q2 2001 | Jun 30, 2001 | — | $-292000.00 | — | — |
Q1 2001 | Mar 31, 2001 | — | $-398364.75 | — | — |
Q4 2000 | Dec 31, 2000 | — | $-82949.00 | — | — |
Q3 2000 | Sep 30, 2000 | — | $-447383.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about ONPH
What is ONPH's current stock price?
Oncology Pharma Inc. (ONPH) is currently trading at $0.01 per share. The stock has moved -50.00% today.
What is the analyst price target for ONPH?
No analyst price targets are currently available for this stock.
What sector is Oncology Pharma Inc. in?
Oncology Pharma Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is ONPH's market cap?
Oncology Pharma Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does ONPH pay dividends?
No, Oncology Pharma Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAMPE
Ampio Pharmaceuticals, Inc.
$0.01
Mkt Cap: $0.0B
ARNI
Arno Therapeutics, Inc.
$0.00
Mkt Cap: $0.0B
BTTX
Better Therapeutics, Inc.
$0.00
Mkt Cap: $0.0B
BXRXQ
Baudax Bio, Inc.
$0.00
Mkt Cap: $0.0B
CALA
Calithera Biosciences, Inc.
$0.00
Mkt Cap: $0.0B
INND
InnerScope Hearing Technologies, Inc.
$0.00
Mkt Cap: $0.0B
IVBT
Innovation1 Biotech Inc.
$0.00
Mkt Cap: $0.0B
PANC
Panacos Pharmaceuticals, Inc.
$0.00
Mkt Cap: $0.0B
TLOG
TetraLogic Pharmaceuticals Corporation
$0.00
Mkt Cap: $0.0B
WUHN
Wuhan General Group (China), Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to ONPH for comparison